Background A decrease in skeletal muscle mass and function, defined as sarcopenia, is
associated with poor postoperative outcome in patients with cancers. Although systemic or …

Background & aims Sarcopenia is characterized by loss of skeletal muscle mass and
associated with poor postoperative outcomes. This study aimed to investigate the prognostic …

Simple Summary Cholangiocellular adenocarcinoma is the second most common primary
liver tumor. If resectable, this is the therapeutic method of choice. Unfortunately, there are …

Abstract Background and Aims Sarcopenia is associated with poor prognosis, but its role in
older patients with intrahepatic cholangiocarcinoma (ICC) is unclear. We aimed to evaluate …

Background: Sarcopenia, systemic inflammation, and low muscularity significantly impact
the survival of cancer patients. However, few studies have investigated how sarcopenia and …

Background Preoperative sarcopenia is a predictor of poor survival in cancer patients. We
hypothesized that sarcopenia could progress as occult metastasis arose, especially after …

Background We studied the prognostic impact of sarcopenia after hepatic resection for
intrahepatic cholangiocarcinoma (ICC). Methods Sixty-one patients who underwent surgery …

Background Decrease in skeletal muscle mass and function, known as sarcopenia, is
associated with poor prognosis. Visceral fat accumulation also is related to mortality. This …

Sarcopenia is considered an important factor affecting the prognosis of cancer patients. Only
complete surgical resection confers the chance of curing cholangiocarcinoma with …

Background The hemoglobin–albumin–lymphocyte–platelet (HALP) score is a combination
index that assesses nutritional status and systemic inflammatory response and is reported to …